S&P 500
(-1.57%) 5 035.69 points
Dow Jones
(-1.49%) 37 816 points
Nasdaq
(-2.04%) 15 658 points
Oil
(-0.74%) $81.32
Gas
(-1.66%) $1.958
Gold
(-0.02%) $2 302.50
Silver
(-0.07%) $26.64
Platinum
(-0.28%) $945.50
USD/EUR
(0.06%) $0.938
USD/NOK
(0.16%) $11.11
USD/GBP
(0.05%) $0.801
USD/RUB
(0.00%) $93.45

Actualizaciones en tiempo real para Nabriva Therapeutics PLC [NBRV]

Bolsa: NASDAQ Sector: Healthcare Industria: Biotechnology
Última actualización31 jul 2023 @ 16:00

0.71% $ 1.420

Live Chart Being Loaded With Signals

Commentary (31 jul 2023 @ 16:00):

Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections...

Stats
Volumen de hoy 706 536
Volumen promedio 13 843.00
Capitalización de mercado 4.55M
EPS $-4.50 ( 2023-08-10 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0722
ATR14 $0.181 (28.73%)
Insider Trading
Date Person Action Amount type
2023-07-06 Hogan H Michael Iii Buy 0
2023-06-30 Maggio David Buy 0
2023-01-29 Gelone Steven P. Sell 140 Ordinary Shares
2023-01-29 Schroeder Theodore R Sell 431 Ordinary Shares
2023-01-06 Gelone Steven P. Sell 5 Ordinary Shares
INSIDER POWER
20.49
Last 98 transactions
Buy: 1 927 900 | Sell: 612 376

Volumen Correlación

Largo: 0.06 (neutral)
Corto: 0.60 (weak)
Signal:(34.114) Neutral

Nabriva Therapeutics PLC Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nabriva Therapeutics PLC Correlación - Moneda/Commodity

The country flag -0.12
( neutral )
The country flag -0.25
( neutral )
The country flag -0.15
( neutral )
The country flag -0.11
( neutral )
The country flag 0.75
( moderate )
The country flag 0.14
( neutral )

Nabriva Therapeutics PLC Finanzas

Annual 2022
Ingresos: $35.67M
Beneficio Bruto: $7.09M (19.87 %)
EPS: $-21.32
FY 2022
Ingresos: $35.67M
Beneficio Bruto: $7.09M (19.87 %)
EPS: $-21.32
FY 2021
Ingresos: $28.90M
Beneficio Bruto: $15.75M (54.50 %)
EPS: $-96.24
FY 2020
Ingresos: $2.86M
Beneficio Bruto: $2.10M (73.25 %)
EPS: $-135.23

Financial Reports:

No articles found.

Nabriva Therapeutics PLC

Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia. It also develops XENLETA that is in Phase I clinical trial for the treatment of pediatric infections, as well as sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated bacterial pneumonia, hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. In addition, the company develops CONTEPO, an epoxide antibiotic for use in treating complicated urinary tract infections, as well as is in Phase I clinical trial for peri-operative prophylaxis. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics plc in 2007. Nabriva Therapeutics plc was incorporated in 2005 and is headquartered in Dublin, Ireland.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico